Notably, the downregulation of ZFP36 and IL6 suppressed the immune infiltration status of NASH, whereas the opposite was true for GRIA3 and FADS2 (Fig. 9E). The gene discussed is FADS2; the disease is metabolic dysfunction-associated steatohepatitis.